HNF-4α inhibits HCC cell proliferation and invasion and promotes apoptosis through negative regulation of the IGFBP-2/Notch1 signaling pathway, providing new experimental evidence for the tumor-suppressive mechanism of HNF-4α in HCC.
Abstract
Abstract: Background: Hepatocyte nuclear factor 4α (HNF-4α) is a liver-enriched transcription factor that is downregulated in hepatocellular carcinoma (HCC). However, the molecular mechanisms by which it regulates the malignant phenotype of HCC cells remain unclear. Objectives: To investigate whether HNF-4α affects HCC cell proliferation, invasion and apoptosis by regulating the IGFBP-2/Notch1 signaling pathway. Methods: HNF-4α was overexpressed and silenced in HepG2 cells using a pcDNA3.1-HNF-4α plasmid and HNF-4α-specific siRNA, respectively. RT-qPCR and Western blotting verified transfection efficiency. Cell proliferation and invasion were assessed by MTT and Transwell assays, respectively. Apoptosis was evaluated by Caspase 3 activity assay. IGFBP-2 secretion was measured by ELISA. Protein expression of Bcl-2, Bax, IGFBP-2 and Notch1 was detected by Western blotting. Results: HNF-4α overexpression significantly inhibited HepG2 cell proliferation (by approximately 35% at 48 h and 45% at 72 h) and invasion (by approximately 55%), while markedly increasing Caspase 3 activity (approximately 2.8-fold) and the Bax/Bcl-2 ratio (from 0.42 to 2.18). Moreover, HNF-4α overexpression significantly suppressed IGFBP-2 secretion (by approximately 60%) and downregulated IGFBP-2 (by approximately 55%) and Notch1 NICD (by approximately 50%) protein expression (all P < 0.001). Conversely, HNF-4α knockdown produced opposite effects, significantly promoting proliferation (by approximately 40% at 48 h and 55% at 72 h) and invasion (by approximately 70%), decreasing Caspase 3 activity (by approximately 55%) and the Bax/Bcl-2 ratio (from 0.45 to 0.19) and upregulating IGFBP-2 (approximately 2.2-fold) and Notch1 NICD (approximately 1.8-fold) expression (all P < 0.01). Conclusion: HNF-4α inhibits HCC cell proliferation and invasion and promotes apoptosis through negative regulation of the IGFBP-2/Notch1 signaling pathway, providing new experimental evidence for the tumor-suppressive mechanism of HNF-4α in HCC.
INTRODUCTION
Hepatocellular carcinoma (HCC) accounts for 75-85% of primary liver cancer cases and remains a major cause of cancer-related mortality worldwide. Despite its high incidence, there is currently no definitive cure for most patients, and the underlying molecular mechanisms are not fully understood.
METHODS...
Wei-Wei Wang, Sen Lu, Feng Jiao et al.· Anti-Cancer Agents in Medici...· 0 citations
Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality worldwide, and current targeted therapeutic options remain inadequate. Gilteritinib, a clinically approved tyrosine kinase inhibitor, has shown antitumor activity in hematologic malignancies; however, its therapeutic...
Si-Jing Chen, Yun-Yang Zhao, Yun-Qi Pan et al.· Biomedicines· 0 citations
It is demonstrated that EZH2 promotes NSCLC progression through activation of the JAK2/STAT3 signaling pathway, identifying the EZH2-JAK2/STAT3 axis as a potential therapeutic vulnerability in this malignancy.
Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.
Meng-Ke Li, Yan Zhao, Yuan Li· Toxicology and Applied Pharm...· 0 citations
It is demonstrated that LGR4 was overexpressed in BPH and localized within the stromal and epithelial components of prostate and regulated the Wnt/β-catenin pathway by interacting with RhoA to control cellular proliferation, apoptosis and EMT, while barely affected cell cycle.
Ji-Zhang Qiu, Huan Liu, Xiao-Long Ma et al.· Biochimica et Biophysica Act...· 0 citations
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and is associated with limited therapeutic options and poor prognosis at advanced stages. Although aberrant activation of importin-β-dependent nuclear transport has been reported in several malignancies, the clinical and therapeutic...
Kübra Sena Baş Topcu· Trakya University Journal of...· 0 citations
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.